Guillain-Barre Syndrome and COVID-19 Vaccine: A Report of Nine Patients
Introduction: Guillain-Barre Syndrome (GBS) is an autoimmune acute inflammatory demyelinating polyneuropathy usually elicited by an upper respiratory tract infection.
Narges Karimi +12 more
doaj
Equity research: AstraZeneca PLC [PDF]
Projeto de mestrado em FinançasO objetivo deste relatório é avaliar a AstraZeneca PLC e a sua estrutura seguirá os padrões do Instituto CFA. Esta empresa foi selecionada principalmente por dois motivos: primeiro, a indústria farmacêutica está em ...
Campião, Ana Carolina Silva
core
Vaccination against COVID-19 is the cornerstone of controlling and mitigating the ongoing pandemic. Thrombotic adverse events linked to Moderna, Pfizer and the Oxford-AstraZeneca vaccine have been documented and described as extremely rare.
Mansour Tobaiqy +3 more
doaj +1 more source
Kvaliteten til AstraZeneca-vaksinen - flere spørsmål enn svar [PDF]
Formålet med studien har vært å vurdere kvaliteten til AstraZeneca-vaksinen ut ifra resultatene og bivirkningene som ble rapportert under de kliniske studiene og bivirkningene som ble rapportert etter at vaksinen har blitt godkjent for administrering ...
Czech, Ilona
core +1 more source
Acquired Thrombotic Thrombocytopenic Purpura after AstraZeneca Vaccine: a Case Report
Background: Rare cases of acquired thrombotic thrombocytopenic purpura (aTTP) have been reported since the administration of the COVID-19 vaccination. Based on our information, the present study provides the first case report of aTTP developed after the ...
Fatemeh Yaghoobi, Davood Dalil
doaj
The potential for durvalumab, a programmed cell death ligand-1 (PD-L1)-blocking monoclonal antibody, to treat head and neck squamous cell carcinoma (HNSCC) is being evaluated in multiple clinical trials.
Rosalinda Arends +7 more
doaj +1 more source
Meta-Analysis Design and Results in Real Life: Problem Solvers or Detour to Maze. A Critical Review of Meta-Analysis of DAPT Randomized Controlled Trials. [PDF]
Therapeutic strategies - such as duration of dual antiplatelet therapy after coronary artery stenting - usually generate a large quantity of meta-analyses. The meta-analyses that include the same randomized clinical trials should produce similar results.
Ramakrishna, Harish +9 more
core +1 more source
Conflictos de intereses El doctor Mattarucco es orador de AstraZeneca y ha realizado o realiza investigación clínica para AstraZeneca, GSK y Novartis. El doctor Goffredo ha recibido honorarios por charlas de AstraZeneca y GSK. El doctor Zunino es orador
Walter Mattarucco
doaj +2 more sources
AstraZeneca/skywalkR-graph-features: v1.0.0
Example notebooks that illustrate how to generate knowledge-based features.
Michaël Ughetto, Anna Gogleva
core +1 more source
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry [PDF]
AIMS: THEMIS is a double-blind, randomized trial of 19,220 patients with diabetes mellitus and stable coronary artery disease (CAD) comparing ticagrelor to placebo, in addition to aspirin.
Simon, Tabassome +27 more
core +1 more source

